Is 5-MAPB Legal in Arizona? (2026)

Instrument

statute

Source

https://www.azleg.gov/ars/13/03401.htm

Retrieved

2026-06-19

Fingerprint

d95ffb8966cc954a

**§ 13-3401(6)(a)(xxx)** "N-methyltryptamine mimetic substances that are any substances derived from N-methyltryptamine by any substitution at the nitrogen, any substitution at the indole ring, any substitution at the alpha carbon, any substitution at the beta carbon or any combination of the above. N-methyltryptamine mimetic substances do not include melatonin (5-methoxy n-acetyltryptamine). **Substances in the N-methyltryptamine generic definition include AcO-DMT, Baeocystine, Bromo-DALT, DiPT, DMT, DPT, HO-DET, HO-DiPT, HO-DMT, HO-DPT, HO-MET, MeO-DALT, MeO-DET, MeO-DiPT, MeO-DMT, MeO-DPT, MeO-NMT, MET, NMT and Norbufotenin.**"
— A.R.S. § 13-3401(6)(a)(xxx), official azleg.gov: https://www.azleg.gov/ars/13/03401.htm

Instrument

Definitions - 'Dangerous drug' hallucinogenic substances (paragraph 6, subdivision (a))

Source

https://www.azleg.gov/ars/13/03401.htm

Retrieved

2026-07-20

Fingerprint

7d8967c94071fba2

6. "Dangerous drug" means the following by whatever official, common, usual, chemical or trade name designated: (a) Any material, compound, mixture or preparation that contains any quantity of the following hallucinogenic substances and their salts, isomers, whether optical, positional or geometric, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation: (i) Alpha-ethyltryptamine. (ii) Alpha-methyltryptamine. (iii) (2-aminopropyl) benzofuran (APB). (iv) (2-aminopropyl)-2, 3-dihydrobenzofuran (APDB). (v) Aminorex. (vi) 4-bromo-2, 5-dimethoxyphenethylamine. (vii) 4-bromo-2, 5-dimethoxyamphetamine. (viii) Bufotenine. (ix) [3-(3-carbamoylphenyl)phenyl]N-cyclohexyl carbamate (URB-597). (x) Diethyltryptamine. (xi) 2, 5-dimethoxyamphetamine. (xii) Dimethyltryptamine. (xiii) (2-ethylaminopropyl)-benzofuran (EAPB). (xiv) 5-methoxy-alpha-methyltryptamine. (xv) 5-methoxy-3, 4-methylenedioxyamphetamine. (xvi) 4-methyl-2, 5-dimethoxyamphetamine. (xvii) (2-methylaminopropyl)-benzofuran (MAPB). (xviii) Ibogaine. (xix) Lysergic acid amide. (xx) Lysergic acid diethylamide. (xxi) Mescaline. (xxii) 4-methoxyamphetamine. (xxiii) Methoxymethylenedioxyamphetamine (MMDA). (xxiv) Methylenedioxyamphetamine (MDA). (xxv) 3, 4-methylenedioxymethamphetamine. (xxvi) 3, 4-methylenedioxy-N-ethylamphetamine. (xxvii) N-ethyl-3-piperidyl benzilate (JB-318). (xxviii) N-hydroxy-3, 4-methylenedioxyamphetamine. (xxix) N-methyl-3-piperidyl benzilate (JB-336). (xxx) N-methyltryptamine mimetic substances that are any substances derived from N-methyltryptamine by any substitution at the nitrogen, any substitution at the indole ring, any substitution at the alpha carbon, any substitution at the beta carbon or any combination of the above. N-methyltryptamine mimetic substances do not include melatonin (5-methoxy n-acetyltryptamine). Substances in the N-methyltryptamine generic definition include AcO-DMT, Baeocystine, Bromo-DALT, DiPT, DMT, DPT, HO-DET, HO-DiPT, HO-DMT, HO-DPT, HO-MET, MeO-DALT, MeO-DET, MeO-DiPT, MeO-DMT, MeO-DPT, MeO-NMT, MET, NMT and Norbufotenin. (xxxi) N-(1-phenylcyclohexyl) ethylamine (PCE). (xxxii) Nabilone. (xxxiii) 1-(1-phenylcyclohexyl) pyrrolidine (PHP). (xxxiv) 1-(1-(2-thienyl)-cyclohexyl) piperidine (TCP). (xxxv) 1-(1-(2-thienyl)-cyclohexyl) pyrrolidine. (xxxvi) Para-methoxyamphetamine (PMA). (xxxvii) Psilacetin. (xxxviii) Psilocybin. (xxxix) Psilocyn. (xl) Synhexyl. (xli) Trifluoromethylphenylpiperazine (TFMPP). (xlii) Trimethoxyamphetamine (TMA). (xliii) 1-pentyl-3-(naphthoyl)indole (JWH-018 and isomers). (xliv) 1-butyl-3-(naphthoyl)indole (JWH-073 and isomers). (xlv) 1-hexyl-3-(naphthoyl)indole (JWH-019 and isomers). (xlvi) 1-pentyl-3-(4-chloro naphthoyl)indole (JWH-398 and isomers). (xlvii) 1-(2-(4-(morpholinyl)ethyl))-3-(naphthoyl)indole (JWH-200 and isomers). (xlviii) 1-pentyl-3-(methoxyphenylacetyl)indole (JWH-250 and isomers). (xlix) (2-methyl-1-propyl-1H-indol-3-YL)-1-naphthalenyl-methanone (JWH-015 and isomers). (l) (6AR, 10AR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan2-Y)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol) (HU-210). (li) 5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)-phenol (CP 47,497 and isomers). (lii) 5-(1,1-dimethyloctyl)-2-(3-hydroxycyclohexyl)-phenol (cannabicyclohexanol, CP-47,497 C8 homologue and isomers). (liii) Xylazine.